secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arch Therapeutics, Inc. (—)
CIK:        0001537561
Form:       8-K
Filed at:   2024-05-06T23:59:59+00:00
Accession:  0001437749-24-014839
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arch Therapeutics extends note maturity to June 30, 2024 and broadens uplist definition
--------------------------------------------------------------------------------

- Amended convertible notes (First, Second, Third, Fourth) to extend maturity from April 30 to June 30, 2024.
- Redefined 'Uplist Transaction' to allow listing on any SEC-registered national securities exchange.
- Amended registration rights agreements (Third A&R and Bridge) to align with new uplist definition.
- Consenting holders representing >51% of registrable securities approved each amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1537561/000143774924014839/0001437749-24-014839-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1537561/000143774924014839/arch20240506_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-24-014839

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer